Impact of levodopa in lung functions in patients with Parkinson disease

Background: Parkinson's disease (PD) is the second-most common neurodegenerative disorder known primarily by its motor symptomatology. These motor manifestations are also hypothesised to affect the respiratory muscular function of PD patients contributing to restrictive pattern of ventilatory d...

Full description

Bibliographic Details
Main Authors: Medha Tandon, Faiz M. H Ahmad, Subramanian Narayanan, Charu Mohan, Simone Yadav
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Annals of Indian Academy of Neurology
Subjects:
Online Access:http://www.annalsofian.org/article.asp?issn=0972-2327;year=2020;volume=23;issue=3;spage=338;epage=341;aulast=
id doaj-21d73d1a1ed34cb69714c8f8379817c3
record_format Article
spelling doaj-21d73d1a1ed34cb69714c8f8379817c32020-11-25T03:47:59ZengWolters Kluwer Medknow PublicationsAnnals of Indian Academy of Neurology0972-23271998-35492020-01-0123333834110.4103/aian.AIAN_88_19Impact of levodopa in lung functions in patients with Parkinson diseaseMedha TandonFaiz M. H AhmadSubramanian NarayananCharu MohanSimone YadavBackground: Parkinson's disease (PD) is the second-most common neurodegenerative disorder known primarily by its motor symptomatology. These motor manifestations are also hypothesised to affect the respiratory muscular function of PD patients contributing to restrictive pattern of ventilatory dysfunction. Previous reports attempting to detect these abnormalities through spirometric assessments have been inconclusive. Attempts at reversal of the restrictive abnormalities by levodopa therapy too, have yielded conflicting results. Objectives: This study aims to classify spirometric abnormalities in asymptomatic PD patients after levopopa withdrawal and document changes after levodopa replacement. Methods: Thirty-six non-smoker PD patients without pre-existing respiratory abnormalities were enrolled. Their standard spirometric values- FEV1, FVC and FEV1/FVC, were noted before and after their morning levodopa dose. Results: Nineteen patients had abnormal PFT values at baseline - 14 restrictive and 5 obstructive defects. Fourteen patients showed improvement in their pulmonary performances after dopamine administration with 6 showing complete reversibility. Statistically significant improvement in the post-levodopa FVC values was seen in patients with restrictive disorder (P value=0.04) but not for obstructive disorders. Discussions: This pilot study characterised that 39% of PD patients had restrictive ventilatory defects prior to morning dopamine administration. Of these, 40% showed improvement after levodopa administration. Conclusion: Restrictive defects are common in PD patients which are evident on routine spirometric screening. These defects are reversible on levodopa administration.http://www.annalsofian.org/article.asp?issn=0972-2327;year=2020;volume=23;issue=3;spage=338;epage=341;aulast=levodoparestrictive defectsspirometry
collection DOAJ
language English
format Article
sources DOAJ
author Medha Tandon
Faiz M. H Ahmad
Subramanian Narayanan
Charu Mohan
Simone Yadav
spellingShingle Medha Tandon
Faiz M. H Ahmad
Subramanian Narayanan
Charu Mohan
Simone Yadav
Impact of levodopa in lung functions in patients with Parkinson disease
Annals of Indian Academy of Neurology
levodopa
restrictive defects
spirometry
author_facet Medha Tandon
Faiz M. H Ahmad
Subramanian Narayanan
Charu Mohan
Simone Yadav
author_sort Medha Tandon
title Impact of levodopa in lung functions in patients with Parkinson disease
title_short Impact of levodopa in lung functions in patients with Parkinson disease
title_full Impact of levodopa in lung functions in patients with Parkinson disease
title_fullStr Impact of levodopa in lung functions in patients with Parkinson disease
title_full_unstemmed Impact of levodopa in lung functions in patients with Parkinson disease
title_sort impact of levodopa in lung functions in patients with parkinson disease
publisher Wolters Kluwer Medknow Publications
series Annals of Indian Academy of Neurology
issn 0972-2327
1998-3549
publishDate 2020-01-01
description Background: Parkinson's disease (PD) is the second-most common neurodegenerative disorder known primarily by its motor symptomatology. These motor manifestations are also hypothesised to affect the respiratory muscular function of PD patients contributing to restrictive pattern of ventilatory dysfunction. Previous reports attempting to detect these abnormalities through spirometric assessments have been inconclusive. Attempts at reversal of the restrictive abnormalities by levodopa therapy too, have yielded conflicting results. Objectives: This study aims to classify spirometric abnormalities in asymptomatic PD patients after levopopa withdrawal and document changes after levodopa replacement. Methods: Thirty-six non-smoker PD patients without pre-existing respiratory abnormalities were enrolled. Their standard spirometric values- FEV1, FVC and FEV1/FVC, were noted before and after their morning levodopa dose. Results: Nineteen patients had abnormal PFT values at baseline - 14 restrictive and 5 obstructive defects. Fourteen patients showed improvement in their pulmonary performances after dopamine administration with 6 showing complete reversibility. Statistically significant improvement in the post-levodopa FVC values was seen in patients with restrictive disorder (P value=0.04) but not for obstructive disorders. Discussions: This pilot study characterised that 39% of PD patients had restrictive ventilatory defects prior to morning dopamine administration. Of these, 40% showed improvement after levodopa administration. Conclusion: Restrictive defects are common in PD patients which are evident on routine spirometric screening. These defects are reversible on levodopa administration.
topic levodopa
restrictive defects
spirometry
url http://www.annalsofian.org/article.asp?issn=0972-2327;year=2020;volume=23;issue=3;spage=338;epage=341;aulast=
work_keys_str_mv AT medhatandon impactoflevodopainlungfunctionsinpatientswithparkinsondisease
AT faizmhahmad impactoflevodopainlungfunctionsinpatientswithparkinsondisease
AT subramaniannarayanan impactoflevodopainlungfunctionsinpatientswithparkinsondisease
AT charumohan impactoflevodopainlungfunctionsinpatientswithparkinsondisease
AT simoneyadav impactoflevodopainlungfunctionsinpatientswithparkinsondisease
_version_ 1724500884897923072